|
Forschungsdatenbank
Forschungsprojekt
|
Projektleiter:
Prof. Dr. Stephan Gehring
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Clinical Study Evaluating the Safety and Immunogenicity of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adult Health Care Workers in Mainz (Germany)
|
Laufzeit:
2020-2025
|
 |
|


|